Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 2
2016 2
2017 1
2018 4
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
MerTK as a therapeutic target in glioblastoma.
Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR. Wu J, et al. Among authors: Schorzman AN. Neuro Oncol. 2018 Jan 10;20(1):92-102. doi: 10.1093/neuonc/nox111. Neuro Oncol. 2018. PMID: 28605477 Free PMC article.
Factors Affecting the Pharmacology of Antibody-Drug Conjugates.
Lucas AT, Price LSL, Schorzman AN, Storrie M, Piscitelli JA, Razo J, Zamboni WC. Lucas AT, et al. Among authors: Schorzman AN. Antibodies (Basel). 2018 Feb 7;7(1):10. doi: 10.3390/antib7010010. Antibodies (Basel). 2018. PMID: 31544862 Free PMC article. Review.
Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer.
Byrne JD, Jajja MRN, O'Neill AT, Schorzman AN, Keeler AW, Luft JC, Zamboni WC, DeSimone JM, Yeh JJ. Byrne JD, et al. Among authors: Schorzman AN. Cancer Chemother Pharmacol. 2018 Jun;81(6):991-998. doi: 10.1007/s00280-018-3570-3. Epub 2018 Mar 30. Cancer Chemother Pharmacol. 2018. PMID: 29603014 Free PMC article.
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
Bowerman CJ, Byrne JD, Chu KS, Schorzman AN, Keeler AW, Sherwood CA, Perry JL, Luft JC, Darr DB, Deal AM, Napier ME, Zamboni WC, Sharpless NE, Perou CM, DeSimone JM. Bowerman CJ, et al. Among authors: Schorzman AN. Nano Lett. 2017 Jan 11;17(1):242-248. doi: 10.1021/acs.nanolett.6b03971. Epub 2016 Dec 22. Nano Lett. 2017. PMID: 27966988 Free PMC article.
Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma.
Byrne JD, Jajja MR, Schorzman AN, Keeler AW, Luft JC, Zamboni WC, DeSimone JM, Yeh JJ. Byrne JD, et al. Among authors: Schorzman AN. Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2200-5. doi: 10.1073/pnas.1600421113. Epub 2016 Feb 8. Proc Natl Acad Sci U S A. 2016. PMID: 26858448 Free PMC article.
2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model.
Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ. Peng L, et al. Among authors: Schorzman AN. Int J Nanomedicine. 2014 Jul 30;9:3601-10. doi: 10.2147/IJN.S66040. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25114529 Free PMC article.
Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity.
Chu KS, Finniss MC, Schorzman AN, Kuijer JL, Luft JC, Bowerman CJ, Napier ME, Haroon ZA, Zamboni WC, DeSimone JM. Chu KS, et al. Among authors: Schorzman AN. Nano Lett. 2014 Mar 12;14(3):1472-6. doi: 10.1021/nl4046558. Epub 2014 Feb 24. Nano Lett. 2014. PMID: 24552251 Free PMC article.
13 results
Jump to page
Feedback